These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26336592)

  • 1. Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema.
    Mehta H; Gillies M; Fraser-Bell S
    Ther Adv Chronic Dis; 2015 Sep; 6(5):234-45. PubMed ID: 26336592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).
    Heng LZ; Sivaprasad S; Crosby-Nwaobi R; Saihan Z; Karampelas M; Bunce C; Peto T; Hykin PG
    Br J Ophthalmol; 2016 Jun; 100(6):802-7. PubMed ID: 26472406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema.
    Dutra Medeiros M; Alkabes M; Nucci P
    Eur Endocrinol; 2014 Aug; 10(2):111-116. PubMed ID: 29872474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Phacoemulsification and Intravitreal Dexamethasone Is an Effective Option for High-Risk Diabetic Macula Oedema Patients.
    Thirunavukarasu AJ; Malem A; Mourtzoukos S
    Cureus; 2021 Aug; 13(8):e17603. PubMed ID: 34646654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
    Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
    Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
    [No Abstract]   [Full Text] [Related]  

  • 6. A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    He Y; Ren XJ; Hu BJ; Lam WC; Li XR
    BMC Ophthalmol; 2018 May; 18(1):121. PubMed ID: 29784048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early efficacy of dexamethasone implant (OZURDEX
    Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2017 May; 40(5):408-413. PubMed ID: 28336283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
    Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
    Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema.
    Bastakis GG; Dimopoulos D; Stavrakakis A; Pappas G
    Eye (Lond); 2019 Mar; 33(3):411-418. PubMed ID: 30302004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone implant in the management of diabetic macular edema from clinician's perspective.
    Urbančič M; Gardašević Topčić I
    Clin Ophthalmol; 2019; 13():829-840. PubMed ID: 31190726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema: Real life safety and efficacy].
    Majstruk L; Qu-Knafo L; Sarda V; Fajnkuchen F; Nghiem-Buffet S; Grenet T; Chaine G; Giocanti-Auregan A
    J Fr Ophtalmol; 2020 Mar; 43(3):197-204. PubMed ID: 32000989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
    Bernard Y; Bonnin N; Farguette F; Chiambaretta F
    J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years.
    Fusi-Rubiano W; Mukherjee C; Lane M; Tsaloumas MD; Glover N; Kidess A; Denniston AK; Palmer HE; Manna A; Morjaria R
    BMC Ophthalmol; 2018 Feb; 18(1):62. PubMed ID: 29486754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of fluid resorption from diabetic macular oedema with foveal serous detachment after dexamethasone intravitreal implant (Ozurdex
    Hodzic-Hadzibegovic D; Ba-Ali S; Valerius M; Lund-Andersen H
    Acta Ophthalmol; 2017 May; 95(3):324-325. PubMed ID: 27778454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry.
    Bhandari S; Gabrielle PH; Nguyen V; Daien V; Viola F; Bougamha W; Young S; Romero-Nuñez B; Figueras-Roca M; Zarranz-Ventura J; Barthelmes D; Sararols L; Gillies M; Creuzot-Garcher C
    Ophthalmol Ther; 2022 Apr; 11(2):797-810. PubMed ID: 35179714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.
    Abdel-Hay A; Sivaprasad S; Subramanian A; Barbur JL
    PLoS One; 2018; 13(6):e0199693. PubMed ID: 29944702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.
    Elhamid AHA
    Open Ophthalmol J; 2017; 11():164-172. PubMed ID: 28839510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.